SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-003341
Filing Date
2018-04-26
Accepted
2018-04-26 16:31:18
Documents
65
Period of Report
2018-01-31

Document Format Files

Seq Description Document Type Size
1 10-K bpmx-20180131x10k.htm 10-K 2804750
2 EX-21.1 bpmx-20180131ex211fcfbdf.htm EX-21.1 1979
3 EX-23.1 bpmx-20180131ex2318ef72b.htm EX-23.1 3436
4 EX-31.1 bpmx-20180131ex3119c0b86.htm EX-31.1 19027
5 EX-31.2 bpmx-20180131ex31237d61e.htm EX-31.2 19670
6 EX-32.1 bpmx-20180131ex321ca66e1.htm EX-32.1 13946
  Complete submission text file 0001558370-18-003341.txt   8139625

Data Files

Seq Description Document Type Size
7 EX-101.INS bpmx-20180131.xml EX-101.INS 1494823
8 EX-101.SCH bpmx-20180131.xsd EX-101.SCH 45913
9 EX-101.CAL bpmx-20180131_cal.xml EX-101.CAL 47921
10 EX-101.DEF bpmx-20180131_def.xml EX-101.DEF 198447
11 EX-101.LAB bpmx-20180131_lab.xml EX-101.LAB 421931
12 EX-101.PRE bpmx-20180131_pre.xml EX-101.PRE 366858
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-K | Act: 34 | File No.: 001-37411 | Film No.: 18779017
SIC: 2834 Pharmaceutical Preparations